These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 2568748)

  • 21. Long-term survival after myocardial infarction: relationship with thrombolysis and discharge medication. Results of the Augsburg Myocardial Infarction Follow-up Study 1985 to 1993.
    Koenig W; Löwel H; Lewis M; Hörmann A
    Eur Heart J; 1996 Aug; 17(8):1199-206. PubMed ID: 8869861
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence of use of beta blockers and of calcium channel blockers in older patients with prior myocardial infarction at the time of admission to a nursing home.
    Aronow WS
    J Am Geriatr Soc; 1996 Sep; 44(9):1075-7. PubMed ID: 8790234
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The use of a beta-blocker esmolol in patients with acute myocardial infarction treated with streptokinase].
    Shalaev SV; Bukhvalov VA; Petrik ES; Shabalkov EA
    Kardiologiia; 2002; 42(6):4-7. PubMed ID: 12494123
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adjunctive pharmacologic therapy for acute myocardial infarction.
    Pepine CJ
    Clin Cardiol; 1994 Jan; 17(1 Suppl 1):I10-4. PubMed ID: 7908862
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The management of patients who have suffered an acute myocardial infarction in a tertiary care centre.
    Haddad H; Searles G; Gillis A
    Can J Cardiol; 2001 Feb; 17(2):179-83. PubMed ID: 11223488
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Esmolol hydrochloride: an ultrashort-acting, beta-adrenergic blocking agent.
    Angaran DM; Schultz NJ; Tschida VH
    Clin Pharm; 1986 Apr; 5(4):288-303. PubMed ID: 2871961
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Managing critically ill patients with esmolol. An ultra short-acting beta-adrenergic blocker.
    Gray RJ
    Chest; 1988 Feb; 93(2):398-403. PubMed ID: 2892647
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of beta blockers, particularly carvedilol, on reducing the risk of events after acute myocardial infarction.
    Kopecky SL
    Am J Cardiol; 2006 Oct; 98(8):1115-9. PubMed ID: 17027583
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adverse outcomes of underuse of beta-blockers in elderly survivors of acute myocardial infarction.
    Soumerai SB; McLaughlin TJ; Spiegelman D; Hertzmark E; Thibault G; Goldman L
    JAMA; 1997 Jan; 277(2):115-21. PubMed ID: 8990335
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Choosing the most appropriate treatment for stable angina. Safety considerations.
    Asirvatham S; Sebastian C; Thadani U
    Drug Saf; 1998 Jul; 19(1):23-44. PubMed ID: 9673856
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-ischaemic therapy during the follow-up phase of acute coronary syndromes. Is there a role for calcium channel blockers?
    Boden WE
    Drugs; 1996; 52 Suppl 4():20-30. PubMed ID: 8913715
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Esmolol: a novel cardioselective, titratable, intravenous beta-blocker with ultrashort half-life.
    Covinsky JO
    Drug Intell Clin Pharm; 1987 Apr; 21(4):316-21. PubMed ID: 2882993
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Usefulness of esmolol in unstable angina pectoris. European Esmolol Study Group.
    Hohnloser SH; Meinertz T; Klingenheben T; Sydow B; Just H
    Am J Cardiol; 1991 Jun; 67(16):1319-23. PubMed ID: 1675036
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacological management of acute myocardial infarction.
    Jain P; Vlay SC
    Clin Cardiol; 1992 Nov; 15(11):795-803. PubMed ID: 10969622
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acute myocardial infarction.
    Danchin N; Urban P; De Benedetti E
    Clin Evid; 2004 Dec; (12):20-50. PubMed ID: 15865629
    [No Abstract]   [Full Text] [Related]  

  • 36. Acute myocardial infarction.
    Danchin N; Urban P; De Benedetti E
    Clin Evid; 2003 Dec; (10):37-63. PubMed ID: 15555085
    [No Abstract]   [Full Text] [Related]  

  • 37. Acute myocardial infarction.
    Danchin N; De Benedetti E; Urban P
    Clin Evid; 2003 Jun; (9):22-49. PubMed ID: 15366134
    [No Abstract]   [Full Text] [Related]  

  • 38. The role of beta-receptor and calcium-entry-blocking agents in acute myocardial infarction in the thrombolytic era: can the results of thrombolytic reperfusion be enhanced?
    Lavie CJ; Murphy JG; Gersh BJ
    Cardiovasc Drugs Ther; 1988 Dec; 2(5):601-7. PubMed ID: 2908710
    [No Abstract]   [Full Text] [Related]  

  • 39. Myocardial infarction.
    Danchin N; Durand E
    Clin Evid; 2006 Jun; (15):140-63. PubMed ID: 16973008
    [No Abstract]   [Full Text] [Related]  

  • 40. [Effects of cardiovascular therapy on risk of the development of ischemia and myocardial infarction in the postoperative period in cancer patients with ischemic heart diseases].
    Stetsenko AE; Kassil' VL; Ushakova TI
    Anesteziol Reanimatol; 2001; (5):55-7. PubMed ID: 11757304
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.